SEP
AMGN icon

Signature Equity Partners’s Amgen AMGN Stock Holding History

Signature Equity Partners’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$350K Buy
965
+49
+5% +$16.8K 0.16% 129
2026
Q1 		$322K Buy
916
+393
+75% +$140K 0.17% 125
2025
Q4 		$171K Buy
+523
New +$166K 0.09% 191

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Signature Equity Partners's AMGN Position: Q2 2026 in Review

Signature Equity Partners increased its Amgen (AMGN) stake by 5.3% in Q2 2026, buying an estimated $16.8K and bringing the position to 965 shares worth $350K. The position accounts for 0.16% of the portfolio, ranked #129.

Signature Equity Partners first reported a position in AMGN in Q4 2025 and has held it in 3 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Signature Equity Partners held 965 shares of Amgen worth $350K as of Q2 2026.
  • Signature Equity Partners bought 49 Amgen shares in Q2 2026, an estimated $16.8K.
  • Amgen made up 0.16% of Signature Equity Partners's portfolio in Q2 2026, its #129 holding.
  • Signature Equity Partners first reported a position in Amgen in Q4 2025 and has held it in 3 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.